On the contrary, strong enrichment of grey matter components, among which CNTN2, was found in the CSF of early MS patients (first episode or clinically isolated syndrome-CIS) when compared to patients and control individuals [105]. The gene discussed is CNTN2; the disease is myeloid sarcoma.